• Profile
Close

Efficacy of furosemide, oral sodium chloride, and fluid restriction for treatment of syndrome of inappropriate antidiuresis (SIAD): An open-label randomized controlled study (The EFFUSE-FLUID Trial)

American Journal of Kidney Diseases Mar 25, 2020

Krisanapan P, et al. - In this open-label randomized controlled study, researchers ascertained if, combined with fluid restriction, furosemide with or without sodium chloride (NaCl) supplementation was more effective than fluid restriction alone in the treatment of hyponatremia in syndrome of inappropriate antidiuresis (SIAD). Participants in the study were 92 patients (FR, n = 31; FR +FM, n = 30; FR+FM+NaCl, n = 31) with serum sodium concentrations ([Na+]) ≤ 130 mmol/L due to SIAD. In patients with SIAD, furosemide with NaCl supplement in conjunction with fluid restriction showed no advantage in [Na+] correction compared with fluid-restricting treatment alone. Patients receiving furosemide have an increased rate of acute kidney injury and hypokalemia.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay